Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

No

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

No

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes

In The News

Investors can take their pick of life sciences companies, with more innovative ideas and treatments being added to pipelines daily. Here’s who brought in the sheaves this week.

The CDC has warned that COVID-19 during pregnancy can result in preterm birth and other negative outcomes, including stillbirths.

Parse Biosciences’ multiplexed approach enables 96 samples and a total of 1 million single cells to be analyzed in parallel without the need for specialized lab instruments.

Although California is already a well-known hotbed for science and technology, the pandemic still precipitated a surge of activity in the life sciences industry.

​The entire lot of CUBICIN (daptomycin), numbered 934778, which has an expiry date of June 2022, will be recalled from the user level, including administering institutions and hospitals.

Redosing is a large and growing concern for gene therapy developers and regulators.

H.C. Wainwright 23rd Annual Global Investment Conference
Virtual September 13-15

Baird Healthcare Conference
Virtual September 14-15

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Virtual September 20-23

UBS Biotechnology Private Company Symposium
Virtual September 22-23

Cantor Fitzgerald Global Healthcare Conference
Virtual September 27-30

Cowen Therapeutics Conference
Virtual October 05-06

See More Events